Deletion of steroid receptor coactivator-3 gene ameliorates hepatic steatosis

Journal of Hepatology

Volumn 55, Issue 2, 2011, Pages 445-452

  Ma, Xinran ^a   Xu, Lingyan ^a   Wang, Shu ^a   Cui, Bin ^a   Li, Xiaoying ^a   Xu, Jianming ^b   Ning, Guang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 2; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; SMALL INTERFERING RNA; STEROID RECEPTOR COACTIVATOR 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; DNA STRUCTURE; FATTY LIVER; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; GENETIC TRANSCRIPTION; HEPATITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LIPID DIET; LIPID METABOLISM; LIPID STORAGE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INTERACTION; RETINOID ACID RESPONSIVE ELEMENT; RNA INTERFERENCE;

ANIMALS; COUP TRANSCRIPTION FACTOR II; DIETARY FATS; DISEASE MODELS, ANIMAL; FATTY LIVER; GENE KNOCKDOWN TECHNIQUES; HEP G2 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LIPID METABOLISM; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NUCLEAR RECEPTOR COACTIVATOR 3; PPAR ALPHA; PROMOTER REGIONS, GENETIC; RECEPTORS, RETINOIC ACID; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRETINOIN;

EID: 79960472726     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.11.022     Document Type: Article

References (36)

1. L.A. Adams, and K.D. Lindor Nonalcoholic fatty liver disease Ann Epidemiol 17 2007 863 869 (Pubitemid 47588954)
2. B.A. Neuschwander-Tetri, and S.H. Caldwell Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference Hepatology 37 2003 1202 1219 (Pubitemid 36538699)
3. N.M. De Alwis, and C.P. Day Non-alcoholic fatty liver disease: the mist gradually clears J Hepatol 48 2008 S104 S112
4. G.C. Farrell, and C.Z. Larter Nonalcoholic fatty liver disease: from steatosis to cirrhosis Hepatology 43 2006 99 112
5. J. Xu, and Q. Li Review of the in vivo functions of the p160 steroid receptor coactivator family Mol Endocrinol 17 2003 1681 1692 (Pubitemid 37072287)
6. C.L. Smith, and B.W. O'Malley Coregulator function: a key to understanding tissue specificity of selective receptor modulators Endocr Rev 25 2004 45 71 (Pubitemid 38292038)
7. B.M. Spiegelman, and R. Heinrich Biological control through regulated transcriptional coactivators Cell 119 2004 157 167 (Pubitemid 39360899)
8. T.C. Leone, J.J. Lehman, B.N. Finck, P.J. Schaeffer, A.R. Wende, and S. Boudina PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis PLoS Biol 3 2005 e101
9. J. Sonoda, I.R. Mehl, L.W. Chong, R.R. Nofsinger, and R.M. Evans PGC-1beta controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis Proc Natl Acad Sci USA 104 2007 5223 5228 (Pubitemid 47186203)
10. G. Leonardsson, J.H. Steel, M. Christian, V. Pocock, S. Milligan, and J. Bell Nuclear receptor corepressor RIP140 regulates fat accumulation Proc Natl Acad Sci USA 101 2004 8437 8442 (Pubitemid 38736593)
11. J. Yan, S.Y. Tsai, and M.J. Tsai SRC-3/AIB1: transcriptional coactivator in oncogenesis Acta Pharmacol Sin 27 2006 387 394
12. J. Xu, L. Liao, G. Ning, H. Yoshida-Komiya, C. Deng, and B.W. O'Malley The steroid receptor coactivator SRC-3 (p/CIP /RAC3 /AIB1/ ACTR/ TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development Proc Natl Acad Sci USA 97 2000 6379 6384 (Pubitemid 30412722)
13. C. Yu, B. York, S. Wang, Q. Feng, J. Xu, and B.W. O'Malley An essential function of the SRC-3 coactivator in suppression of cytokine mRNA translation and inflammatory response Mol Cell 25 2007 765 778 (Pubitemid 46341916)
14. F. Picard, M. Géhin, J. Annicotte, S. Rocchi, M.F. Champy, and B.W. O'Malley SRC-1 and TIF2 control energy balance between white and brown adipose tissues Cell 111 2002 931 941 (Pubitemid 36044686)
15. J.F. Louet, A. Coste, L. Amazit, M. Tannour-Louet, R.C. Wu, and S.Y. Tsai Oncogenic steroid receptor coactivator-3 is a key regulator of the white adipogenic program Proc Natl Acad Sci USA 103 2006 17868 17873 (Pubitemid 44852252)
16. A. Coste, J.F. Louet, M. Lagouge, C. Lerin, M.C. Antal, and H. Meziane The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1α Proc Natl Acad Sci USA 105 2008 17187 17192
17. S. Joshi-Barve, S.S. Barve, K. Amancherla, L. Gobejishvili, D. Hill, and M. Cave Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes Hepatology 46 2007 823 830 (Pubitemid 47436129)
18. Z.M. Younossi, A.M. Diehl, and J.P. Ong Nonalcoholic fatty liver disease: an agenda for clinical research Hepatology 35 2002 746 752 (Pubitemid 34258367)
19. Nabeshima Yoshitaka, Tazuma Susumu, Kanno Keishi, Hyogo Hideyuki, and Chayama Kazuaki Deletion of angiotensin II type I receptor reduces hepatic steatosis J Hepatol 50 2009 1226 1235
20. J. Xu, and B.W. O'Malley Molecular mechanisms and cellular biology of the steroid receptor coactivator (SRC) family in steroid receptor function Rev Endocr Metab Disord 3 2002 185 192
21. J.M. Maglich, D.C. Lobe, and J.T. Moore The nuclear receptor CAR (NR1I3) regulates serum triglyceride levels under conditions of metabolic stress J Lipid Res 50 2009 439 445
22. I. Pineda Torra, Y. Jamshidi, D.M. Flavell, J.C. Fruchart, and B. Staels Characterization of the human PPARalpha promoter: identification of a functional nuclear receptor response element Mol Endocrinol 16 2002 1013 1028 (Pubitemid 34478538)
23. V. Giguere, E.S. Ong, P. Segui, and R.M. Evans Identification of a receptor for the morphogen retinoic acid Nature 330 1987 624 629 (Pubitemid 18005577)
24. S.E. Shoelson, J. Lee, and A.B. Goldfine Inflammation and insulin resistance J Clin Invest 116 2006 1793 1801 (Pubitemid 44033299)
25. C. Carter-Kent, N.N. Zein, and A.E. Feldstein Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment Am J Gastroenterol 103 2008 1036 1042 (Pubitemid 351501089)
26. A.C. Li, C.J. Binder, A. Gutierrez, K.K. Brown, C.R. Plotkin, and J.W. Pattison Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma J Clin Invest 114 2004 1564 1576 (Pubitemid 40385547)
27. G. Rizzo, and S. Fiorucci PPARs and other nuclear receptors in inflammation Curr Opin Pharmacol 6 2006 421 427
28. X. Ma, L. Xu, S. Wang, H. Chen, J. Xu, and X. Li Loss of steroid receptor co-activator-3 attenuates carbon tetrachloride-induced murine hepatic injury and fibrosis Lab Invest 89 2009 903 914
29. P.J. Barter, and K.A. Rye Cardioprotective properties of fibrates: which fibrate, which patients, what mechanism? Circulation 113 2006 1553 1555 (Pubitemid 43739413)
30. S. Kersten, J. Seydoux, J.M. Peters, F.J. Gonzalez, B. Desvergne, and W. Wahli Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting J Clin Invest 103 1999 1489 1498
31. Park Joo-In, Y. Sophia, and Tsai Ming-Jer Molecular mechanism of chicken ovalbumin upstream promoter-transcription factor (COUP-TF) actions Tsai Keio J Med 52 2003 174 181
32. X. Leng, A.J. Cooney, S.Y. Tsai, and M.J. Tsai Molecular mechanisms of COUP-TF-mediated transcriptional repression: evidence for transrepression and active repression Mol Cell Biol 16 1996 2332 2340 (Pubitemid 26123754)
33. M.U. De Martino, S. Alesci, G.P. Chrousos, and T. Kino Interaction of the glucocorticoid receptor and the chicken ovalbumin upstream promoter- transcription factor II (COUP-TFII): implications for the actions of glucocorticoids on glucose, lipoprotein, and xenobiotic metabolism Ann N Y Acad Sci 1024 2004 72 85 (Pubitemid 38879594)
34. P. Bardoux, P. Zhang, D. Flamez, A. Perilhou, T.A. Lavin, and J.F. Tanti Essential role of chicken ovalbumin upstream promoter-transcription factor II in insulin secretion and insulin sensitivity revealed by conditional gene knockout Diabetes 54 2005 1357 1363 (Pubitemid 40586664)
35. M. Okamura, H. Kudo, K. Wakabayashi, T. Tanaka, A. Nonaka, and A. Uchida COUP-TFII acts downstream of Wnt/beta-catenin signal to silence PPARgamma gene expression and repress adipogenesis Proc Natl Acad Sci USA 106 2009 5819 5824
36. L. Li, X. Xie, J. Qin, G.S. Jeha, P.K. Saha, and J. Yan The nuclear orphan receptor COUP-TFII plays an essential role in adipogenesis, glucose homeostasis, and energy metabolism Cell Metab 9 2009 77 87